Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Juliana Rocha Santos"'
Autor:
Paulo Roberto Xavier Tomaz, Thuane Sales Gonçalves, Juliana Rocha Santos, Jaqueline Scholz, Tânia Ogawa Abe, Patrícia Viviane Gaya, Eduardo Costa Figueiredo, Henrique Dipe de Faria, Isarita Martins, Ana Miguel Fonseca Pego, Beatriz Aparecida Bismara, Maurício Yonamine, Alexandre Costa Pereira, Paulo Caleb Júnior Lima Santos
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
Background: Smoking is the leading cause of preventable death worldwide. It is responsible for several types of cancer, cardiovascular diseases, and diseases of the reproductive system, among others. Therefore, advances in research are increasingly n
Externí odkaz:
https://doaj.org/article/ece744ca90af460190c5194891d83508
Autor:
Paulo Roberto Xavier Tomaz, Juliana Rocha Santos, Jaqueline Scholz, Tânia Ogawa Abe, Patrícia Viviane Gaya, André Brooking Negrão, José Eduardo Krieger, Alexandre Costa Pereira, Paulo Caleb Júnior Lima Santos
Publikováno v:
BMC Medical Genetics, Vol 19, Iss 1, Pp 1-8 (2018)
Abstract Background The identification of variants in the nicotinic acetylcholine receptor (nAChR) subunit genes associated with smoking phenotypes are increasingly important for prevention and treatment of nicotine dependence. In the context of pers
Externí odkaz:
https://doaj.org/article/acadfd4de2b6432c80d904223e68a87a
Autor:
Juliana Rocha Santos, Paulo Roberto Xavier Tomaz, Jaqueline Scholz Issa, Tania Ogawa Abe, Jose Eduardo Krieger, Alexandre Costa Pereira, Paulo C J L Santos
Publikováno v:
Frontiers in Genetics, Vol 6 (2015)
The large individual variability in response to drugs for smoking cessation suggests that specific treatments can be more effective in particular subgroups of smokers. In the context of personalized medicine, the main aim of the present study was to
Externí odkaz:
https://doaj.org/article/55aafd9dca044c0ab0c8d4a6adb2b2ef
Autor:
Bianca Boura Bellini, Juliana Rocha Santos, Paulo C. Jr. de Lima Santos, Iana R. A. de Moraes, Tania O. Abe, Jaqueline Scholz, Serena Tonstad, Patricia Viviane Gaya, Paulo Roberto Xavier Tomaz
Publikováno v:
Tobacco Prevention and Cessation, Vol 7, Iss May, Pp 1-10 (2021)
Tobacco Prevention & Cessation
Tobacco Prevention & Cessation
Introduction Varenicline effectively helps smokers quit by reducing withdrawal symptoms and blocking the reward of smoking. However, most quitters return to smoking within one year. ‘Cue Restricted Smoking’ is a behavioral technique designed to i
Autor:
José Eduardo Krieger, Paulo Roberto Xavier Tomaz, Alexandre C. Pereira, Jaqueline Scholz, Patricia Viviane Gaya, Paulo Caleb Junior Lima Santos, Tânia Ogawa Abe, Juliana Rocha Santos
Publikováno v:
Genes
Volume 11
Issue 7
Genes, Vol 11, Iss 746, p 746 (2020)
Volume 11
Issue 7
Genes, Vol 11, Iss 746, p 746 (2020)
Introduction: Smoking is considered the leading cause of preventable morbidity and mortality worldwide. Studies have sought to identify predictors of response to smoking cessation treatments. The aim of this study was to analyze a possible associatio
Autor:
José Eduardo Krieger, Jaqueline Scholz, Paulo Roberto Xavier Tomaz, Tânia Ogawa Abe, Paulo Caleb Junior Lima Santos, André B. Negrão, Patricia Viviane Gaya, Alexandre C. Pereira, Juliana Rocha Santos
Publikováno v:
BMC Medical Genetics, Vol 19, Iss 1, Pp 1-8 (2018)
BMC Medical Genetics
Repositório Institucional da UNIFESP
Universidade Federal de São Paulo (UNIFESP)
instacron:UNIFESP
Repositório Institucional da USP (Biblioteca Digital da Produção Intelectual)
Universidade de São Paulo (USP)
instacron:USP
BMC Medical Genetics
Repositório Institucional da UNIFESP
Universidade Federal de São Paulo (UNIFESP)
instacron:UNIFESP
Repositório Institucional da USP (Biblioteca Digital da Produção Intelectual)
Universidade de São Paulo (USP)
instacron:USP
FAPESP CNPq, Brazil CAPES, Brazil Background: The identification of variants in the nicotinic acetylcholine receptor (nAChR) subunit genes associated with smoking phenotypes are increasingly important for prevention and treatment of nicotine dependen
Autor:
Tânia Ogawa Abe, José Eduardo Krieger, Mariana Soares Kajita, Paulo Roberto Xavier Tomaz, Patricia Viviane Gaya, Jaqueline Scholz, Paulo Caleb Junior Lima Santos, Alexandre C. Pereira, Juliana Rocha Santos
Publikováno v:
European journal of clinical pharmacology. 75(11)
The identification of variants in genes involved in nicotine metabolism may have implications for the pharmacological therapy of smoking. In the scenario of precision medicine, the aim of this study was to evaluate a possible association of cytochrom
Autor:
Renata Caroline Costa de Freitas, Ivan Dieb Miziara, Paulo Caleb Junior Lima Santos, Vilma Leyton, Mario Hiroyuki Hirata, Paulo Roberto Xavier Tomaz, Mauricio Yonamine, Raul Hernandes Bortolin, Juliana Rocha Santos, Ana Miguel Fonseca Pego
Publikováno v:
Repositório Institucional da USP (Biblioteca Digital da Produção Intelectual)
Universidade de São Paulo (USP)
instacron:USP
Universidade de São Paulo (USP)
instacron:USP
Violence and drug abuse are highly destructive phenomena found world-wide, especially in Brazil. They seem to rise proportionally to one another and possibly related. Additionally, genetics may also play a role in drug abuse. This study has focused o
Autor:
Juliana Rocha Santos, José Eduardo Krieger, Paulo Roberto Xavier Tomaz, Alexandre C. Pereira, Paulo Caleb Junior Lima Santos, Tânia Ogawa Abe, Jaqueline Scholz Issa, Patricia Viviane Gaya
Publikováno v:
European Journal of Clinical Pharmacology. 71:1067-1073
Previous studies suggested that polymorphisms in the CYP2B6 gene (which encodes an isoenzyme that metabolizes bupropion) and in the ANKK1 gene (which is located in the ANKK1/DRD2 gene cluster) might influence response to therapy. Thus, the aim of the
Autor:
Alexandre C. Pereira, Jaqueline Scholz Issa, Juliana Rocha Santos, Paulo Caleb Junior Lima Santos, Tania Ogawa Abe, Paulo Roberto Xavier Tomaz, José Eduardo Krieger
Publikováno v:
Frontiers in Genetics, Vol 6 (2015)
Frontiers in Genetics
Frontiers in Genetics
Background: The large individual variability in response to drugs for smoking cessation suggests that specific treatments can be more effective in particular subgroups of smokers. In the context of personalized medicine, the main aim of the present s